These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10600691)

  • 41. Antibiotic resistance and virulence: Understanding the link and its consequences for prophylaxis and therapy.
    Guillard T; Pons S; Roux D; Pier GB; Skurnik D
    Bioessays; 2016 Jul; 38(7):682-93. PubMed ID: 27248008
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The decline of antibiotic era--new approaches for antibacterial drug discovery.
    Jagusztyn-Krynicka EK; Wyszyńska A
    Pol J Microbiol; 2008; 57(2):91-8. PubMed ID: 18646395
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prioritizing drug targets in Clostridium botulinum with a computational systems biology approach.
    Muhammad SA; Ahmed S; Ali A; Huang H; Wu X; Yang XF; Naz A; Chen J
    Genomics; 2014 Jul; 104(1):24-35. PubMed ID: 24837790
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The search for novel antibiotics--strategies and current approaches].
    Schmid P
    Berl Munch Tierarztl Wochenschr; 2014; 127(11-12):498-512. PubMed ID: 25872259
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genome-scale metabolic models as platforms for identification of novel genes as antimicrobial drug targets.
    Mienda BS; Salihu R; Adamu A; Idris S
    Future Microbiol; 2018 Mar; 13():455-467. PubMed ID: 29469596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genomic approaches to understanding bacterial virulence.
    Burrack LS; Higgins DE
    Curr Opin Microbiol; 2007 Feb; 10(1):4-9. PubMed ID: 17161645
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bacterial genomes and infectious diseases.
    Chan VL
    Pediatr Res; 2003 Jul; 54(1):1-7. PubMed ID: 12646714
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Renaissance in Antibiotic Discovery: Some Novel Approaches for Finding Drugs to Treat Bad Bugs.
    Gadakh B; Van Aerschot A
    Curr Med Chem; 2015; 22(18):2140-58. PubMed ID: 25787965
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The fallacies of hope: will we discover new antibiotics to combat pathogenic bacteria in time?
    Vicente M; Hodgson J; Massidda O; Tonjum T; Henriques-Normark B; Ron EZ
    FEMS Microbiol Rev; 2006 Nov; 30(6):841-52. PubMed ID: 17064283
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibiotics and pharmacogenomics.
    Davison DB; Barrett JF
    Pharmacogenomics; 2003 Sep; 4(5):657-65. PubMed ID: 12943472
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The utility of complete genome sequences in the study of pathogenic bacteria.
    Hood DW
    Parasitology; 1999; 118 Suppl():S3-9. PubMed ID: 10466132
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Everything at once: comparative analysis of the genomes of bacterial pathogens.
    Laing CR; Zhang Y; Thomas JE; Gannon VP
    Vet Microbiol; 2011 Nov; 153(1-2):13-26. PubMed ID: 21764529
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel target sites in bacteria for overcoming antibiotic resistance.
    Black MT; Hodgson J
    Adv Drug Deliv Rev; 2005 Jul; 57(10):1528-38. PubMed ID: 15949866
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Microbial genome analysis: insights into virulence, host adaptation and evolution.
    Wren BW
    Nat Rev Genet; 2000 Oct; 1(1):30-9. PubMed ID: 11262871
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of essential genes in Streptococcus pneumoniae using bioinformatics and allelic replacement mutagenesis.
    Song JH; Ko KS
    Methods Mol Biol; 2008; 416():401-8. PubMed ID: 18392984
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Type III bacterial secretion system, a promising target for the development of a new generation of antibiotic drugs].
    Gintsburg AL; Zigangirova NA; Zorina VV
    Vestn Ross Akad Med Nauk; 2008; (10):34-9. PubMed ID: 19140396
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk assessment prediction from genome sequences: promises and dreams.
    Wassenaar TM
    J Food Prot; 2004 Sep; 67(9):2053-7. PubMed ID: 15453601
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microbial pathogenesis: genomics and beyond.
    Strauss EJ; Falkow S
    Science; 1997 May; 276(5313):707-12. PubMed ID: 9115190
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Strategies to Block Bacterial Pathogenesis by Interference with Motility and Chemotaxis.
    Erhardt M
    Curr Top Microbiol Immunol; 2016; 398():185-205. PubMed ID: 27000091
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Microbial genomes and vaccine design: refinements to the classical reverse vaccinology approach.
    Mora M; Donati C; Medini D; Covacci A; Rappuoli R
    Curr Opin Microbiol; 2006 Oct; 9(5):532-6. PubMed ID: 16890009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.